Journals / Turkish Journal of Rheumatology(.)Archives of Rheumatology / 2012 / Cilt: 27 - Sayı: 2

Successful Treatment of Diffuse Alveolar Hemorrhage with Recombinant Factor VIIa in a Child with Henoch-Schönlein Purpura

Pages
145–147
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

KOCA, T. G., KUYBULU, A. E., ÇİRİŞ, İ. M., ÖKTEM, F., ÖRMECİ, A. R., ALANOĞLU, E. G. (2022). Successful Treatment of Diffuse Alveolar Hemorrhage with Recombinant Factor VIIa in a Child with Henoch-Schönlein Purpura. Turkish Journal of Rheumatology(.)Archives of Rheumatology, Cilt: 27 - Sayı: 2, 145–147. https://ajindex.com/articles/614178

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Trapani S, Micheli A, Grisolia F, Resti M, Chiappini E, Falcini F, et al. Henoch Schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature. Semin Arthritis Rheum 2005;35:143-53. Chaussain M, de Boissieu D, Kalifa G, Epelbaum S, Niaudet P, Badoual J, et al. Impairment of lung diffusion capacity in Schönlein-Henoch purpura. J Pediatr 1992;121:12-6.
  2. Shin JI, Lee JS. Could intravenous cyclosporin A be an effective therapeutic strategy in pulmonary hemorrhage associated with Henoch-Schönlein purpura? Comment on: Pulmonary hemorrhage associated with Henoch-Schönlein purpura in a child. Clin Rheumatol 2008;27:803-5.
  3. Besbas N, Duzova A, Topaloglu R, Gok F, Ozaltin F, Ozen S, et al. Pulmonary haemorrhage in a 6-year-old boy with Henoch-Schönlein purpura. Clin Rheumatol 2001;20:293-6.
  4. Tiryaki O, Buyukhatipoglu H, Karakok M, Usalan C. Successful treatment of a rare complication of Henoch- Schönlein purpura in advanced age: pulmonary hemorrhage. Intern Med 2007;46:905-7.
  5. Kalyoncu M, Cakir M, Erduran E, Okten A. Henoch- Schönlein purpura: a case with atypical presentation. Rheumatol Int 2006;26:669-71.
  6. Lusher JM, Roberts HR, Davignon G, Joist JH, Smith H, Shapiro A, et al. A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group. Haemophilia 1998;4:790-8.
  7. Colin AA, Shafieian M, Andreansky M. Bronchoscopic instillation of activated recombinant factor VII to treat diffuse alveolar hemorrhage in a child. Pediatr Pulmonol 2010;45:411. Tatopoulos A, Herbain D, Kazmierczak C, Bollaert PE, Gibot S. Parenteral use of recombinant activated factor VII during diffuse alveolar hemorrhage secondary to leptospirosis. Intensive Care Med 2010;36:555-6.
  8. Dabar G, Harmouche C, Jammal M. Efficacy of recombinant activated factor VII in diffuse alveolar haemorrhage. Rev Mal Respir 2011;28:106-11. [Abstract] Yildirim H, Ucgun I, Yalcin AU, Gulbaş Z, Sahin G, Acikalin MF, et al. Recombinant factor VIIa treatment for life-threatening haemoptysis. Respirology 2006;11:652-4.